EphA3 is a novel molecular target in Multiple Myeloma
收藏官方服务：
资源简介：
EphA3 is a novel molecular target in Multiple Myeloma
应用场景：
创建时间：
2017-06-30
相关数据集
Additional file 5: of PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs
Table S4. EZH2i target genes are mostly bivalent in XG7 HMCLs (XLSX 10Â kb)
NIAID Data Ecosystem50
CD86 regulates a pro-survival signal in myeloma cells. Homo sapiens
While multiple myeloma patient prognosis has improved over the past decade, research towards discovery of new therapeutic avenues is important, and could lead to a cure for this chronic plasma cell ma
NIAID Data Ecosystem30
Additional file 9: of PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs
Table S5. H3K27me3-associated and EPZ-6438-regulated genes (XLSX 12 kb)
Figshare2018-10-04 更新10
NCP26 is a potent prolyl-tRNA synthetase inhibitor and induces pro- apoptotic responses with in vivo potency in multiple myeloma. Single-cell RNA-seq data BM samples.
Glutamyl-prolyl-tRNA synthetase (EPRS) is a unique bifunctional aminoacyl-tRNA synthetase which catalyzes the ATP-dependent aminoacylation of glutamyl and prolyl residues to cognate tRNAs, constitutin
NIAID Data Ecosystem50
DataSheet_1_Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma.docx
The endothelin-1 (ET-1) receptors were recently found to mediate pro-survival functions in multiple myeloma (MM) cells in response to autocrine ET-1. This study investigated the effectiveness of macit
NIAID Data Ecosystem20
